<p>C57BL/6 mice were injected s.c. in one flank with 640,000 wild type Panc02 cells. At 11, 18, and 25 days (arrows) post tumor injection, mice were injected i.m. contralaterally with PBS or 7.6 x 10<sup>7</sup> pfu/mouse of MVA, MVAmeso (Meso) or MVAmesoA35Del (A35D) viruses in 25 ul. (A) Tumor volumes were measured 3 times per week and survival (B) was monitored.</p
<p>Mice were injected s.c. with B16 cells on day 0. Mice were immunized s.c. with 1x10<sup>6</sup> D...
<p>Mice were subcutaneously immunized with PBS or TcdB-exposed CT26 cells (TcdB). In some experiment...
<p>(<b>A</b>) Evolution of the tumor volume in mice pretreated with i.v. injections every 2 days of ...
<p>(A) Mice were vaccinated 2 times and then injected with tumor cells 2 weeks later. (B) Tumors wer...
<p>C57BL/6 mice (5 mice per group) were implanted with subcutaneous B16-F10 tumor cells. 7 days late...
<p><b>A</b>) NSG mice were subcutaneously injected in the right flank with 2x10<sup>7</sup> MCV-posi...
<p>(A) Tumors growth was measured from day 20–32 (post-cell injection) and treated every other day *...
<p>The time of morbidity was recorded for mice (each group, n = 10) inoculated with live tumor cells...
<p>Mice were i.v injected with saline (20 mg/kg, 0.160 mmol/kg), 5-FA-PAE (284 mg/kg, 0.160 mmol/kg)...
<p>Tumor-bearing mice were treated with 10, 25 or 50 mg/kg of mAb AFS98 or PBS, IP, starting from da...
<p>BOWES PCMV6 and CXCR3 cells were injected interdermally into NSG mice (5 x 10<sup>5</sup> cells p...
<p>(a). Mice (3–4 months old) were subcutaneously injected with 0.25×10<sup>6</sup> B16 melanoma cel...
<p>C57BL/6 mice (n = 3 per group) were implanted with unilateral subcutaneous B16-F10 tumor cells. T...
<p>(A) SNU638 cells were transfected with MED30 or SCR siRNA and then injected subcutaneously into t...
<p>Neuro-2a murine neuroblastoma tumor cells (5 × 10<sup>5</sup> cells) were injected into the right...
<p>Mice were injected s.c. with B16 cells on day 0. Mice were immunized s.c. with 1x10<sup>6</sup> D...
<p>Mice were subcutaneously immunized with PBS or TcdB-exposed CT26 cells (TcdB). In some experiment...
<p>(<b>A</b>) Evolution of the tumor volume in mice pretreated with i.v. injections every 2 days of ...
<p>(A) Mice were vaccinated 2 times and then injected with tumor cells 2 weeks later. (B) Tumors wer...
<p>C57BL/6 mice (5 mice per group) were implanted with subcutaneous B16-F10 tumor cells. 7 days late...
<p><b>A</b>) NSG mice were subcutaneously injected in the right flank with 2x10<sup>7</sup> MCV-posi...
<p>(A) Tumors growth was measured from day 20–32 (post-cell injection) and treated every other day *...
<p>The time of morbidity was recorded for mice (each group, n = 10) inoculated with live tumor cells...
<p>Mice were i.v injected with saline (20 mg/kg, 0.160 mmol/kg), 5-FA-PAE (284 mg/kg, 0.160 mmol/kg)...
<p>Tumor-bearing mice were treated with 10, 25 or 50 mg/kg of mAb AFS98 or PBS, IP, starting from da...
<p>BOWES PCMV6 and CXCR3 cells were injected interdermally into NSG mice (5 x 10<sup>5</sup> cells p...
<p>(a). Mice (3–4 months old) were subcutaneously injected with 0.25×10<sup>6</sup> B16 melanoma cel...
<p>C57BL/6 mice (n = 3 per group) were implanted with unilateral subcutaneous B16-F10 tumor cells. T...
<p>(A) SNU638 cells were transfected with MED30 or SCR siRNA and then injected subcutaneously into t...
<p>Neuro-2a murine neuroblastoma tumor cells (5 × 10<sup>5</sup> cells) were injected into the right...
<p>Mice were injected s.c. with B16 cells on day 0. Mice were immunized s.c. with 1x10<sup>6</sup> D...
<p>Mice were subcutaneously immunized with PBS or TcdB-exposed CT26 cells (TcdB). In some experiment...
<p>(<b>A</b>) Evolution of the tumor volume in mice pretreated with i.v. injections every 2 days of ...